In addition, bioinformatics analysis of the expression and prognosis of JMJD6 in a variety of tumors showed that high expression of JMJD6 was significantly associated with poor overall survival (OS) in ESCC patients. This evidence concerns the gene JMJD6 and esophageal squamous cell carcinoma.